Carregant...

The Efficacy and Safety of Low‐ and High‐ Dose Fixed Combinations of Irbesartan/Hydrochlorothiazide in Patients With Uncontrolled Systolic Blood Pressure on Monotherapy: The INCLUSIVE Trial

This multicenter, prospective, open‐label, single‐arm study determined the efficacy and safety of irbesartan/hydrochlorothiazide (HCTZ) fixed combinations in patients (n=1005), aged 18 years and older, with uncontrolled systolic blood pressure (SBP) of 140–159 mm Hg (130–159 mm Hg for type 2 diabete...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Hypertens (Greenwich)
Autors principals: Neutel, Joel M., Saunders, Elijah, Bakris, George L., Cushman, William C., Ferdinand, Keith C., Ofili, Elizabeth O., Sowers, James R., Weber, Michael A.
Format: Artigo
Idioma:Inglês
Publicat: Le Jacq Ltd. 2007
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8109614/
https://ncbi.nlm.nih.gov/pubmed/16227760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2004.04720.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!